Skip to content
10-Q

Quarterly Report

Grace Therapeutics, Inc. GRCE

0001140361-26-004924

← back to feed
Filed
Feb 12, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2026 · Feb 12, 2026 15.47M sh
Shares Diluted Q3 2026 · Dec 31, 2025 16.93M sh
Shares Diluted Q3 2026 · Dec 31, 2025 16.26M sh
Shares Diluted Q3 2026 · Dec 31, 2024 11.51M sh
Shares Diluted Q3 2026 · Dec 31, 2024 11.51M sh
Operating Cash Flow Q3 2026 · Dec 31, 2025 −$7.17M
Operating Cash Flow Q3 2026 · Dec 31, 2024 −$11.95M
Cash And Equivalents Q3 2026 · Dec 31, 2025 $18.67M
Cash And Equivalents Q3 2026 · Mar 31, 2025 $22.13M
Stockholders Equity Q3 2026 · Dec 31, 2025 $64.89M
Stockholders Equity Q3 2026 · Sep 30, 2025 $62.82M
Stockholders Equity Q3 2026 · Jun 30, 2025 $63.55M
Stockholders Equity Q3 2026 · Mar 31, 2025 $66.61M
Stockholders Equity Q3 2026 · Dec 31, 2024 $52.14M
Stockholders Equity Q3 2026 · Sep 30, 2024 $56.13M
Stockholders Equity Q3 2026 · Jun 30, 2024 $59.36M
Stockholders Equity Q3 2026 · Mar 31, 2024 $61.74M
Current Liabilities Q3 2026 · Dec 31, 2025 $1.28M
Current Liabilities Q3 2026 · Mar 31, 2025 $1.93M
Total Liabilities Q3 2026 · Dec 31, 2025 $3.6M
Total Liabilities Q3 2026 · Mar 31, 2025 $5.38M
Current Assets Q3 2026 · Dec 31, 2025 $19.21M
Current Assets Q3 2026 · Mar 31, 2025 $22.71M
Total Assets Q3 2026 · Dec 31, 2025 $68.49M
Total Assets Q3 2026 · Mar 31, 2025 $71.99M
Eps Diluted Q3 2026 · Dec 31, 2025 −$0.14
Eps Diluted Q3 2026 · Dec 31, 2025 −$0.41
Eps Diluted Q3 2026 · Dec 31, 2024 −$0.36
Eps Diluted Q3 2026 · Dec 31, 2024 −$0.89
Eps Basic Q3 2026 · Dec 31, 2025 −$0.14
Eps Basic Q3 2026 · Dec 31, 2025 −$0.41
Eps Basic Q3 2026 · Dec 31, 2024 −$0.36
Eps Basic Q3 2026 · Dec 31, 2024 −$0.89
Sga Expense Q3 2026 · Dec 31, 2025 $1.99M
Sga Expense Q3 2026 · Dec 31, 2025 $6.08M
Sga Expense Q3 2026 · Dec 31, 2024 $1.51M
Sga Expense Q3 2026 · Dec 31, 2024 $5.62M
Rd Expense Q3 2026 · Dec 31, 2025 $462K
Rd Expense Q3 2026 · Dec 31, 2025 $1.99M
Rd Expense Q3 2026 · Dec 31, 2024 $2.19M
Rd Expense Q3 2026 · Dec 31, 2024 $7.88M
Net Income Q3 2026 · Dec 31, 2025 −$2.32M
Net Income Q3 2026 · Dec 31, 2025 −$6.62M
Net Income Q3 2026 · Sep 30, 2025 −$938K
Net Income Q3 2026 · Jun 30, 2025 −$3.36M
Net Income Q3 2026 · Dec 31, 2024 −$4.16M
Net Income Q3 2026 · Dec 31, 2024 −$10.2M
Net Income Q3 2026 · Sep 30, 2024 −$3.43M
Net Income Q3 2026 · Jun 30, 2024 −$2.62M
Operating Income Q3 2026 · Dec 31, 2025 −$2.45M
Operating Income Q3 2026 · Dec 31, 2025 −$8.07M
Operating Income Q3 2026 · Dec 31, 2024 −$3.7M
Operating Income Q3 2026 · Dec 31, 2024 −$13.5M